Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001156 · ClinicalTrials.gov registry record
Assessment of Patients With Multiple Sclerosis (MS)
A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 1,388
- Enrollment target
NCT00001156 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 1,388 participants.
The verdict
NCT00001156 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 1,388 participants
- Enrollment target
Study Summary
Multiple sclerosis (MS) is a disease of the nervous system. The exact cause of MS is unknown, but it is believed to be an autoimmune condition. Autoimmune conditions are diseases that cause the body's immune system and natural defenses to attack healthy cells. In the case of MS, the immune system begins attacking myelin, the cells that make up the sheath covering nerves. Without myelin, nerves are unable to transmit signals effectively and symptoms occur. This study is directed toward a better understanding of the cause of Multiple Sclerosis (MS). Researchers will evaluate patients with a tentative diagnosis of MS or other neurological diseases possibly caused by a immunological reaction. Patients will undergo a series of three MRIs, taken once a month for three months and submit blood samples for immunological studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,388 participants |
| Start Date | 1976-01-23 |
| Est. Completion | 2010-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001156
The ClinicalTrials.gov registry entry for NCT00001156 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,388 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001156 about?
NCT00001156 is a clinical study titled "Assessment of Patients With Multiple Sclerosis (MS)". Multiple sclerosis (MS) is a disease of the nervous system. The exact cause of MS is unknown, but it is believed to be an autoimmune condition. Autoimmune conditions are diseases that cause the body's immune system and natural defenses to attack healthy cells. In the case of MS, the immune system be...
What is the current status of trial NCT00001156?
This trial is currently completed. The enrollment target is 1,388 participants. The study started on 1976-01-23. Estimated completion is 2010-02-01.
Who is sponsoring clinical trial NCT00001156?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.